Diagnosing Alzheimer’s disease: are we any nearer to useful biomarker-based, non-invasive tests?

Background: Alzheimer’s disease (AD) accounts for 60–80% of cases of dementia and causes significant morbidity in patients and carers, and expense for health and social services. There is a need for a validated, non-invasive and cheap test to diagnose early AD, as diagnosis may enable prompt treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Fletcher, Lydia C. B., Burke, Katie E., Caine, Paul L., Rinne, Natasha L., Braniff, Charlotte A., Davis, Hannah R., Miles, Kathryn A., Packer, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677379/
https://www.ncbi.nlm.nih.gov/pubmed/23755087
http://dx.doi.org/10.3205/hta000107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677379/
https://www.ncbi.nlm.nih.gov/pubmed/23755087
http://dx.doi.org/10.3205/hta000107

Ejemplares similares